Daniele Zanoni

Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer

Antonino Musolino, Laura Ciccolallo, Michele Panebianco et al. · Cancer · 2010 · 135 citations · Full text

Medicine, Oncology, Breast Oncology +16

<i><scp>ALK</scp></i> and <i>ROS1</i> rearrangements tested by fluorescence <i>in situ</i> hybridization in cytological smears from advanced non‐small cell lung cancer patients

Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo et al. · Diagnostic Cytopathology · 2015 · 46 citations

Medicine, Genetics, Oncology +17

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Antonino Musolino, Nadia Naldi, Maria Vittoria Dieci et al. · The Pharmacogenomics Journal · 2016 · 28 citations · Full text

Medicine, Immunology, Oncology +14

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

A. Viansone, Benedetta Pellegrino, Claudia Omarini et al. · The Breast · 2022 · 19 citations · Full text

Medicine, Genetics, Oncology +16